Vascular dementia in the elderly
All dementias related to cerebrovascular factors are collectively referred to as cerebrovascular dementia (vascular dementia). First of all, it must be pointed out that dementia actually refers to a syndrome in which brain function declines, especially the overall decline of intelligence-related functions, and the decline reaches a certain degree. It usually includes a series of symptoms and signs such as memory, cognition, emotions and behaviors, and lasts for several months or more than half a year. Vascular factors mainly refer to the blood vessels in the brain, namely the two major systems of carotid arteries and vertebral basilar arteries. It can be lesions of these blood vessels themselves, or lesions of large extracranial blood vessels and the heart, which indirectly affect the blood vessels in the brain, resulting in insufficient blood supply and ischemic and hypoxic changes in brain tissue, and ultimately causing a comprehensive decline in brain function.
Related Drugs
Aniracetam Capsules
Indication: 1. Vascular dementia and Alzheimer's disease with mild to moderate learning, memory and cognitive dysfunction. 2. Mild to moderate cognitive and behavioral disorders after stroke. 3. Benign memory impairment in the middle-aged and elderly.
Manufacturer:
Wuxi Cathy Pharmaceuticals Ltd.
Oxiracetam Capsules
Indication: It is suitable for memory and intellectual disorders caused by mild to moderate vascular dementia, senile dementia and brain trauma.
Manufacturer:
CSPC OUYI Pharmaceutical Co., Ltd.
Huperzine A
Indication: It is suitable for benign memory disorders and improves patients' ability of directed memory, associative learning, image recall, meaningless pattern recognition and portrait recall. It also has an improving effect on memory disorders caused by dementia patients and organic brain lesions.
Manufacturer:
Zhejiang Zhenyuan Pharmaceutical Co., Ltd.
Cerebroprotein Hydrolysate Injection
Indication: -Primary dementia (such as Alzheimer's type senile dementia). -Vascular dementia (such as multi-infarct dementia, etc.) and cognitive dysfunction after mild or moderate stroke. -Mixed dementia. -Improvement of brain dysfunction after craniocerebral injury.
Manufacturer:
Jilin Aodong--Taonan Pharnalentical Company Ltd